Loading...
Paragon 28, Inc.
FNA•NYSE
Healthcare
Medical - Devices
$13.09
$0.00(0.00%)
Paragon 28, Inc. (FNA) Financial Performance & Income Statement Overview
Review Paragon 28, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
18.39%
↑ 18.39%
Operating Income Growth
10.70%
↑ 10.70%
Net Income Growth
5.03%
↑ 5.03%
Operating Cash Flow Growth
57.51%
↑ 57.51%
Operating Margin
-15.05%
↓ 15.05%
Gross Margin
75.39%
↑ 75.39%
Net Profit Margin
-20.48%
↓ 20.48%
ROE
-36.11%
↓ 36.11%
ROIC
-15.89%
↓ 15.89%
Paragon 28, Inc. (FNA) Income Statement & Financial Overview
Review Paragon 28, Inc.'s (FNA) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $71.75M | $62.34M | $61.02M | $61.08M |
Cost of Revenue | $19.43M | $16.16M | $15.26M | $12.19M |
Gross Profit | $52.32M | $46.18M | $45.76M | $48.90M |
Gross Profit Ratio | $0.73 | $0.74 | $0.75 | $0.80 |
R&D Expenses | $6.74M | $5.66M | $7.08M | $7.58M |
SG&A Expenses | $52.01M | $48.97M | $49.44M | $54.22M |
Operating Expenses | $58.75M | $54.63M | $56.52M | $61.80M |
Total Costs & Expenses | $78.18M | $70.79M | $71.78M | $73.98M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $2.96M | $3.03M | $2.92M | $2.62M |
Depreciation & Amortization | $4.97M | $4.71M | $4.61M | $4.26M |
EBITDA | -$2.63M | -$4.40M | -$6.03M | -$10.35M |
EBITDA Ratio | -$0.04 | -$0.07 | -$0.10 | -$0.17 |
Operating Income | -$6.43M | -$8.45M | -$10.77M | -$12.90M |
Operating Income Ratio | -$0.09 | -$0.14 | -$0.18 | -$0.21 |
Other Income/Expenses (Net) | -$4.13M | -$3.68M | -$2.79M | -$2.11M |
Income Before Tax | -$10.56M | -$12.13M | -$13.55M | -$15.01M |
Income Before Tax Ratio | -$0.15 | -$0.19 | -$0.22 | -$0.25 |
Income Tax Expense | $558000.00 | $205000.00 | $230000.00 | $224000.00 |
Net Income | -$11.12M | -$12.34M | -$13.78M | -$15.23M |
Net Income Ratio | -$0.15 | -$0.20 | -$0.23 | -$0.25 |
EPS | -$0.13 | -$0.15 | -$0.17 | -$0.18 |
Diluted EPS | -$0.13 | -$0.15 | -$0.17 | -$0.18 |
Weighted Avg Shares Outstanding | $83.31M | $83.56M | $83.12M | $82.85M |
Weighted Avg Shares Outstanding (Diluted) | $83.31M | $83.56M | $83.12M | $82.85M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan